CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $343,000 | -38.6% | 5,468 | -25.9% | 0.02% | -47.1% |
| Q4 2021 | $559,000 | -39.5% | 7,380 | -10.6% | 0.03% | -34.6% |
| Q3 2021 | $924,000 | +4.6% | 8,254 | +43.1% | 0.05% | -18.8% |
| Q4 2020 | $883,000 | -50.8% | 5,770 | -73.1% | 0.06% | +10.3% |
| Q3 2020 | $1,796,000 | -53.6% | 21,472 | -59.2% | 0.06% | -42.0% |
| Q2 2020 | $3,870,000 | +9.9% | 52,662 | -36.5% | 0.10% | +7.5% |
| Q1 2020 | $3,520,000 | +10.1% | 82,992 | +58.0% | 0.09% | +106.7% |
| Q4 2019 | $3,198,000 | – | 52,515 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |